Epidemiological profile of patients with multiple myeloma who developed pulmonary complications after hematopoietic stem cell transplantation

Jaime Leonardo Chacón Manosalva, Luis Antonio Salazar Montaña, Angela María Peña Castellanos, Manuel Leonidas Rosales Acevedo (Co-autor), Jonathan Javier Díaz Jurado, Ana Maria Prada Sepulveda, Miguel Enrique Ochoa Vera, Gabriela Vesga Jerez, Maria Angelica Chacon Manosalva, Claudia Lucia Sossa Melo

Producción científica: Artículos / NotasArtículo Científicorevisión exhaustiva

Resumen

Multiple myeloma (MM) is a neoplastic entity for which Hematopoietic Stem Cell Transplantation (HSCT) is a therapeutic option. Between 30–60% of patients managed with HSCT have pulmonary complications (PC). The aim of this study was to identify the clinical and sociodemographic characteristics associated with the incidence of PC in patients with MM after HSCT (post-HSCT) at Clinica FOSCAL.
Idioma originalIndefinido/desconocido
Número de artículoP412
Páginas (desde-hasta)324-325
Número de páginas1
PublicaciónBone Marrow Transplantation
Volumen57
N.ºpag. 326
DOI
EstadoPublicada - 1 nov. 2022

Palabras clave

  • mulplipe myeloma

Líneas de Investigación UNAB

  • Medicina Interna

Citar esto